TRPV4 mutator (Actio Biosciences)

N/A

Report date: 2025/06/11 11:24:55
NME

Base Information

Drug NameTRPV4 mutator (Actio Biosciences)
Drug Alias NameN/A
ClassificationSmall molecules
Mechanisms of ActionTransient receptor potential cation channel subfamily V antagonists
TargetsTransient receptor potential cation channel subfamily V
Therapy Area/IndicationsMetaphyseal dysplasiaCharcot-Marie-Tooth 2A
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited States
CombinationsNo
Global Highest StatusPreclinical
Highest Status in ChinaN/A
Originator CompaniesActio Biosciences Inc
China Registration ClassN/A

Develop Information

Active CompaniesActio Biosciences Inc
Inactive CompaniesN/A
Active IndicationsMetaphyseal dysplasiaCharcot-Marie-Tooth 2A
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A